Physician profile
Joseph Chalal
NPI 1962454082
$586.40
in general payments reported to CMS, 2019-2025
15 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.52 · 2020: $26.55 · 2021: $162 · 2022: $22.62 · 2023: $39.31 · 2024: $122 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $105.97 | 2021-2024 | Monovisc |
| Kaleo, INC. | $92.05 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $60.51 | 2025 | Iovera, Zilretta, Exparel |
| Nalu Medical, INC. | $42.89 | 2021-2025 | Nalu Neurostimulation System |
| Vericel Corporation | $42.60 | 2024-2025 | Maci |
| Stryker Corporation | $35.56 | 2024 | T2 Alpha |
| Zimmer Biomet Holdings, INC. | $33.79 | 2019-2021 | |
| Bioventus LLC | $30.45 | 2021-2025 | Durolane |
| Pacira Therapeutics, INC. | $26.55 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $25.38 | 2025 | |
| Orthofix Medical, INC. | $23.66 | 2023 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $17.47 | 2019 | |
| Avanos Medical | $17.02 | 2019 | |
| Medtronic, INC. | $16.85 | 2025 | Closurefast |
| Kowa Pharmaceuticals America, INC. | $15.65 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.